company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,128900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,128900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,55600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,46800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-78100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,153200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,153200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-27400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,97000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,58800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,58800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-112600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-306500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,206300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,63800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-134100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-134100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,76900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,7300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 17:01:48+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,37200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,229100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,229100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,58700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-70800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-51700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,165300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,165300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-64000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,97900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,40100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,40100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-213900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-95500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,130300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,66700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-91800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-91800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,115400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,FY,2009-01-01,2009-12-31,2012-02-27 16:28:20+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,34200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,47600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,47600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,65900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,65900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,5500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-15900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,22800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-7400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,46500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q4,2009-10-01,2009-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,34200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,73500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,73500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-49800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,32400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,71500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,71500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,61900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,53300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,53300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-44500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-25100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,30000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-26300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-26300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3,2009-07-01,2009-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,104500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,181500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,181500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,44500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-71200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-55400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,99400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,99400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-40300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,92400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,56000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,56000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-202200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-79600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,129300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,43900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-95700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-95700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,9200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q3YTD,2009-01-01,2009-09-30,2010-11-08 16:52:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,68900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,108000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,108000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-21400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-87800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,27900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,27900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-28200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,30500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-157700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-54500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,99300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,33200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-69400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-69400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2009.0,Q2YTD,2009-01-01,2009-06-30,2010-08-06 16:17:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-35600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,64800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,64800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,94000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,94000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-95600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,37600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,18300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,13100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-26600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-26600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,35100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q4,2010-10-01,2010-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,218000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,218000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,56500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-10800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-12300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,251400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,251400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-61800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-61500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-61500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-305500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-200000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,254400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,92100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,55100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-103900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-103900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-24000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,62000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,FY,2010-01-01,2010-12-31,2013-02-28 16:41:02+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,200800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,200800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,55300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-12300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-20500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,223300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,223300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-63800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,10600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-54300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-54300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-221600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-215900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,217800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,96600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,49700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-73400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-73400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-22200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,73400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3TTM,2009-10-01,2010-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,34200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,35100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,96400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,96400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-110500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,23700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-56600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-56600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,16100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,40700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,153200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,153200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,41100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-12700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-24200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,157400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,157400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-40100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-38400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-38400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-209900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-200000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,216800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,73800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,42000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-77300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-77300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-14800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q3YTD,2010-01-01,2010-09-30,2011-11-08 16:11:35+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,26900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,226300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,226300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,57300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-62000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-23200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,198400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,198400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-59500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,71000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-155600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-240300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,224100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,86900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,41800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-43100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-43100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-32300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,137200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2TTM,2009-07-01,2010-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,34200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,57500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,57500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-25400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,48000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-34000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-101300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,88600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-14300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-14300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-17900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2,2010-04-01,2010-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,105200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,105200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,27700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-12600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-59300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,61000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,61000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-23200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-23200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-99400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-199300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,193100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,53400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,31500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-20700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-20700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-30900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q2YTD,2010-01-01,2010-06-30,2011-08-08 17:12:28+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,47700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,47700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-14800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-33900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,13000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,13000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-8000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-65400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-98000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,104500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,33300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,19200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-13000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2010.0,Q1,2010-01-01,2010-03-31,2011-05-09 16:10:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,63100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,24900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,93400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,93400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-5400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-191600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,9100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,112500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-6900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-108300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-108300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-46700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-40100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,19900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-53600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-53600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-72800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q4,2011-10-01,2011-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,15400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,236700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,236700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,58000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,50100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-36600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,308200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,308200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-76600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-50300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-645600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,9100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,353000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-406500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-406500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-423400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-303400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,526100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,59500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-135200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-135200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-224900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,FY,2011-01-01,2011-12-31,2014-02-28 16:35:10+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,15400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,238400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,238400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,58600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,27100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-15300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,308800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,308800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-72300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-44900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-461000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,5400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,240500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,8800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-321300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-321300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-472300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-263300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,543800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,66900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,16700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-108200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-108200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-117000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,51600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,51600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,30800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,115400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,115400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-19500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-149700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,222600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,55300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,55300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-305400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-104300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,304900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,15200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-7600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-97200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-97200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,68400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,173600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,173600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,43200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-27200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,214800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,214800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-50600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-44900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-454000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,240500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,6900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-298200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-298200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-376700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-263300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,506200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,48600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-81600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-81600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,12900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q3YTD,2011-01-01,2011-09-30,2012-11-06 19:29:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-152100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,234800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,234800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,58100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,289800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,289800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-69200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-44900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-310900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,6200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-391800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-391800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-277400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-159700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,262600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,72100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,34800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-67600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-67600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,24900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-144700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,58100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,58100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,84500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,84500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-17200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-198000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-195400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-195400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-66100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-83200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,89200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-43900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-43900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-149600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,122000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,122000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,29300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-58000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,99400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,99400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-31100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-44900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-304300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,5000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-353500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-353500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-71300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-159000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,201300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,33400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,11200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,15600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,15600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,18000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q2YTD,2011-01-01,2011-06-30,2012-08-06 19:11:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-220500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,234200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,234200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,57000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-8000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-29900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,253300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,253300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-67700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-42900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-113000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,4500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-213100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-213100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-245300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-177800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,262000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,72000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,51100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-38000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-38000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,2400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1TTM,2010-04-01,2011-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,14700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,63900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-12000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-51500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,14900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,14900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-42900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-106300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,5000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-158100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-158100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-75800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,112100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,59500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,59500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,12800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 20:42:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-70900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,89400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,89400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,17700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,114700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,114700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-44100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-36600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-68900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,174200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,27400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,27400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-155900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-186900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,167700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,10700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-146900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-146900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,9900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q4,2012-10-01,2012-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,38000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,291500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,291500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,53700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,21100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,362100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,362100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-109000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-43600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-595200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,662300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-78800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-78800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-367500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-353200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,408500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,100100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,56500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-155600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-155600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,12000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,139700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,FY,2012-01-01,2012-12-31,2015-02-20 16:03:43+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,38000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,265200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,265200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,57000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,24600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,340800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,340800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-90900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-12400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-717900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,9100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,600600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-214500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-214500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-258300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-206400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,260700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,100300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,41400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-62300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-62300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,61800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,15400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,69200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,69200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,31300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,131300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,131300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-25700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-279700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,172300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-131900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-131900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-42600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-13100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,34200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,25000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,202100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,202100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,42200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,247400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,247400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-64900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-526300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,488100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-106200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-106200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-211600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-166300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,240800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,89400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,39000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q3YTD,2012-01-01,2012-09-30,2013-11-07 17:02:24+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,134600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,247600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,247600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,56500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,27300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,324900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,324900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-84700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-12400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-587900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,9100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,650900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-521100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-297600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,531400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,90500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,37800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-159000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-159000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,128700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,15400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,51800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,146800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,146800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-140500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,125500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-42700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-42700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-48500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-52900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,52000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,39500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-8000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,91000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,132900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,132900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,27800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-16700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-27900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,116100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,116100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-246600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,315800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,25700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,25700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-169000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-153200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,206600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,64400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,43000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-8200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-8200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q2YTD,2012-01-01,2012-06-30,2013-08-06 17:00:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,133100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,237900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,237900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,57300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,32200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-64800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,262600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,262600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-80700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-645400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,9100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,543300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-180000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-180000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-538700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-327900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,568600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,71200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,29000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-197800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-197800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-111900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,3200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,15400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,65100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,65100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,13800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-29900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-79700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-106100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,190300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,68400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,68400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-120500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-100300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,154600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,24900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,38200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,7500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2012.0,Q1,2012-01-01,2012-03-31,2013-05-06 16:46:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,42100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,389100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,389100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,62900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-19400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,40100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,472700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,472700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-109000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-827600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,526400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-412700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-412700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-895400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-496900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1308200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,73500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,14600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,109500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,4300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,FY,2013-01-01,2013-12-31,2016-02-19 16:17:10+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,54000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,75100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,75100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,111300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,111300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-453100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,223600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-246900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-246900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-535600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,597300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,80500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,80500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-50600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q4,2013-10-01,2013-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,21900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,403400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,403400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,57300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-30200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,45600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,476100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,476100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-133000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-36600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-443400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,477000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-138400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-138400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-515700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-683800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,878600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,47600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,80800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-192500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-192500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,20000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,165200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,70100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,76800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,76800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,30200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,132200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,132200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-22600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-152300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,71900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-106500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-106500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-250300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,372800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,68600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,68600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,98300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3,2013-07-01,2013-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,32100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,314000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,314000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,45800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-26300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,27900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,361400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,361400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-88900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-374500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,302800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-165800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-165800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-359800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-496900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,710900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,36900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,63300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-45600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-45600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,10100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,160100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q3YTD,2013-01-01,2013-09-30,2014-10-31 16:06:09+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,32100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,395800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,395800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,54700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-22000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,46700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,475200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,475200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-136100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-36600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-570800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,577400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-163800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-163800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-490500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-446600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,540000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,63100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,72400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-261600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-261600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,18600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,68400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,38000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,93300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,93300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,128100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,128100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-29500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-129400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,85700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-73000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-73000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-133700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-138900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,172400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-89300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-89300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,237200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,237200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,28800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-34500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,229200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,229200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-66300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-222200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,230900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-59300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-59300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-292000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-246600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,338100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,27400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,58900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-114200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-114200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,6100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q2YTD,2013-01-01,2013-06-30,2014-08-04 16:04:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,61800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,370300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,370300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,54000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-24600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,94200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,493900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,493900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-127800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-43600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-581900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,617200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-133500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-133500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-405300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-360600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,419600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,89000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,79900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-177400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-177400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,188200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,38000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,143900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,143900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-50300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,101100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,101100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-36800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-92800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,145200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-158300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-107700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,165700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,61600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-24900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-24900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2013.0,Q1,2013-01-01,2013-03-31,2014-05-02 16:06:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,90600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,811100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,811100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,68600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,119200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1022300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1022300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-82900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-25800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2116800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1612900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-25600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-633000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-633000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-241100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,226300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,113300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,49400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-153000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-153000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,233400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,15500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,FY,2014-01-01,2014-12-31,2017-02-17 17:01:03+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,274700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,109200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,109200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-48300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,93200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,93200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-25800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-505000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,700300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-28200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,112000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,112000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-17100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,15200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,45900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,45900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,249700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,15500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q4,2014-10-01,2014-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,74400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,701900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,701900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,50300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,167500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,929100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,929100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-48400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1611800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,912600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-745000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-745000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-224000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,220300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,71300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,34200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-198900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-198900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3YTD,2014-01-01,2014-09-30,2015-10-28 19:43:27+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,200300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,777000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,777000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,67400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,179700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1040400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1040400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-68500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2064900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1136200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,3800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-991900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-991900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-759600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,817600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,79900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,44400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-118400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-118400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-66900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,222200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,94600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,94600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-105900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,12200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,12200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-454400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,317700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-154800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-154800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,38400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,48700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,48700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-94500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q3,2014-07-01,2014-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,200300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,607300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,607300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,273400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,916900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,916900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-30300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1157400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,594900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-590200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-590200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-215300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,214100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,32900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,21300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-247600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-247600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2YTD,2014-01-01,2014-06-30,2015-07-29 16:10:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,78200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,759200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,759200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,66400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,315800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1160400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1160400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-73000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1762800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,890400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-943600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-943600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-818700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-550900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1184200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,51000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,35900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-98500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-98500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,7600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,125900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,54000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,547000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,547000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,211900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,778000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,778000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-755200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,298100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-470400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-470400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-135000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,18700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-103800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-103800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,202900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,60300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,60300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,61500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,138900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,138900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-402200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,296800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-119800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-119800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-80300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-300000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,208300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,14200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-143800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-143800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 16:14:46+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-124700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,305500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,305500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,65000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,31800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,108200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,510500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,510500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-86500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1137000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,678000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-546200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-546200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-817400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-689200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1350800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,25900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-84000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-84000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,13900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-105800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,4300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,54000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,494900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,494900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,65800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-30600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,549700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,549700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-102700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-335400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1308800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1439700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-11900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-316100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-316100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-38400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-280100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,31400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,87200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,41300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-158600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-158600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-10400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,64600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,14100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,FY,2015-01-01,2015-12-31,2018-02-16 16:10:41+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,86900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,140700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,140700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,14500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-53700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,103800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,103800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-37500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-15300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-98100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,178300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,27300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,27300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-100000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,27200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-59700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-59700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,72300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,14100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q4,2015-10-01,2015-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,49700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,354200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,354200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,51300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,23100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,445900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,445900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-65200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-320100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1210700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1261400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-8800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-343400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-343400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-26600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-180100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,20700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,60000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-98900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-98900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-11300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3YTD,2015-01-01,2015-09-30,2016-10-27 19:47:01+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,37200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,463400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,463400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,69600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,31300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-25200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,539100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,539100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-99700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-345900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1715700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1961700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-37000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-231400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-231400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-43700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-180300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,26700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,102000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,42300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-53000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-53000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-12700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,242000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,15500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,111600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,118100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,118100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,52600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,202500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,202500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-320100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-450700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,620800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-175600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-175600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,17500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,23600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,23600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,48500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q3,2015-07-01,2015-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,37200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,236100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,236100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-29500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,243400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,243400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-39200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-760000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,640600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-167800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-167800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-18100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-179900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,13300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,42500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,19700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-122500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-122500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2YTD,2015-01-01,2015-06-30,2016-07-28 19:58:10+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-56200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,439900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,439900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,69100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,23500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-183700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,348800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,348800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-91800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-25800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1719400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1658600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-37400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-210600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-210600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-43900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-180200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,25500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,122900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,47800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-27900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-27900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-11300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,99000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,15500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,274700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,112700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,39100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-253000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,291400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-78900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,19000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-50600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-50600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,8600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,140600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,123400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,123400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-68600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,73300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,73300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-507000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,349200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-180300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-180300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-11600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-101000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,23500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-71900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-71900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-17900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 20:07:25+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-196800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,874200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,874200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,68400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,25000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-10900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,956700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,956700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-89400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-25800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2221600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1665300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-27200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-693500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-693500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-172400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-101900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,25400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,122600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,45200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-81100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-81100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-20800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,161300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,15500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,274700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,569500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,569500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,71200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,35000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,28700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,704400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,704400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-176100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-48900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1074900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1085100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-211700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-211700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-31400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-662300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,257600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,103300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,64300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-268500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-268500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-12500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,FY,2016-01-01,2016-12-31,2019-02-15 16:22:49+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,211700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,158500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,158500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,13300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,201100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,201100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-63200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-7600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-158300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,295300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,12100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,80200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,80200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-246400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,228900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,285100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,411000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,411000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,52100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,24800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,15400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,503300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,503300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-112900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-41300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-916600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,789800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-10900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-291900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-291900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-25700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-415900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,28700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,82700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,56600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-273600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-273600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-11200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3YTD,2016-01-01,2016-09-30,2017-10-27 16:11:05+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-73400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,551700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,551700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,66600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,27100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-38300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,607100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,607100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-150400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-56600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1014700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,968100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-14000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-264600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-264600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-37500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-515900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,39400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,109900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,70800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-333300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-333300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-10300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,14100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,49700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,141400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,141400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,50200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,205900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,205900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-48100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-287300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,347700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-8200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,38100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,19400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,63800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,63800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,275100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,269600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,269600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,33900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,28700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-34800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,297400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,297400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-64800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-41100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-629300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,442100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-295800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-295800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-19400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-415700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,44600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,37200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-337400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-337400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-12700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2YTD,2016-01-01,2016-06-30,2017-07-28 16:11:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-348500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,528400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,528400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,66900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,44300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-35900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,603700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,603700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-128300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-376500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1178100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1241200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-444100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-444100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-39700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-515900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,34000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,89300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,58800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-373500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-373500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-13800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-227700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,14100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,86900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,126600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,126600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,24500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,21200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,190300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,190300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-37100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-41100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-403400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,139400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-343100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-343100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-14100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,25100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,26100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,31700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,31700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-10400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-131500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,143000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,143000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,15900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-56000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,107100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,107100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-225900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,302700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,47300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,47300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-401600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,11400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,19500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,11100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-369100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-369100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1,2016-01-01,2016-03-31,2017-04-28 16:06:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-217000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,514500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,514500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,65700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,21300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-18000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,583500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,583500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-109600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-335400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1027700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1393200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-12000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-88500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-88500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-36300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-580700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,35400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,83200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,42600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-455800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-455800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,44400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,14100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,86900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,583600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,583600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,81900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,93100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,242100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1000700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1000700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-168100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-225300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1334700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1103400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-22500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-647200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-647200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-818400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-763300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,994700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,113800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-473200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-473200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,FY,2017-01-01,2017-12-31,2020-02-14 16:13:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-119700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,334200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,363900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,363900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-51900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-140400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-140000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,389400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,49300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,49300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-251300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,22500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-229000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-229000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,180100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,586400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,586400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,60700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,81800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-92100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,636800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,636800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-116200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-84900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1194700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,714000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-14700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-696500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-696500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-812800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-512000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,989300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,91300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-244200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-244200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3YTD,2017-01-01,2017-09-30,2018-10-25 20:39:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-299800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,744900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,744900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,79800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,92000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-78800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,837900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,837900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-179400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-92500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1353000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1009300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-616300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-616300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-818500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-758400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1218200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,111900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-239100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-239100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,170100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,15600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,104400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,310800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,310800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,6300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-356800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,192600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-209500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-209500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,22600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,122100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,416300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,416300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,40000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,66200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-196500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,326000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,326000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-73900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-91200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-837900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,521400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-5700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-487000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-487000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-808200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-511200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,986200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,68700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-264500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-264500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2YTD,2017-01-01,2017-06-30,2018-07-27 16:07:30+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-421900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,716200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,716200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,77300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,72500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-133000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,733000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,733000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-185200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-99000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1283500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,2200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1164400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-402900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-402900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-820200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-757800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1227900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,127400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-195600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-195600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,138300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,186100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,186100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,18900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,46000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-53300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,197700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,197700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-58000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-6500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-670500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,98600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-638200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-638200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-453800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-73800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,608800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,126800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,126800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-311100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,230200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,230200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-143200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,128300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,128300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-15900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-84700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-167400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,422800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,151200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,151200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-354400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-437400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,377400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,23100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-391300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-391300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1,2017-01-01,2017-03-31,2018-04-27 16:06:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-110800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,656700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,656700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,76400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,51000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-58500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,725600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,725600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-164300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-133600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1016400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,1900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1205200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-107800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-107800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-376300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-698100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,623600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,106900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,53200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-290700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-290700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,317900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,722200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,722200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,77400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,202800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-75600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,926800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,926800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-238700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-459300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,801300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-23600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,76700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,76700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1125600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-795500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,688000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,147000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-15100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1101200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1101200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,FY,2018-01-01,2018-12-31,2020-02-14 16:13:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-97700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,144800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,121300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,293000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,293000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-57600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-154000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,220100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-601500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-272000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,27700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-844700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-844700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,5300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-540700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,715200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,715200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,57500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,58000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-196900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,633800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,633800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-181100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-305300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,581200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-20800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,71000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,71000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-524100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-523500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,686900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,119300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-15100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-256500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-256500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3YTD,2018-01-01,2018-09-30,2019-10-25 16:08:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,443000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,712400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,712400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,78700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,69300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,137300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,997700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,997700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-233000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-143400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-445300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,970600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-28600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,120300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,120300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-529700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-774800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,692300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,141800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-15100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-485500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-485500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,623100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,225900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,225900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,78800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,342300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,342300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-85100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-305300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,140600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-254200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-254200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-93100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,35000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-56700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-56700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,34900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,489300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,489300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,38300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,39600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-275700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,291500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,291500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-96000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-3000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,440600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-16400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,325200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,325200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-524400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-430400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,685800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,84300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-15100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-199800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-199800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-8800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2YTD,2018-01-01,2018-06-30,2019-07-26 16:05:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,408100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,656600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,656600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,80200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,66500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,162900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,966200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,966200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-190200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-137100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-496800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,-300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1022600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-33200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,165000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,165000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-534600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-682500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,694300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,129400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-15100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-408500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-408500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-12400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,710300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,282700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,282700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,20200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-181900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,140200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,140200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-52800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,1800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,159800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,104900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,104900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-517500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-428300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,680700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,39500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-15100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-240700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-240700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,206600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,206600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-93800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,151300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,151300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-43200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,280800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-9400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,220300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,220300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-6900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-2100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,44800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,40900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,40900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1,2018-01-01,2018-03-31,2019-04-26 16:09:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,408700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,560000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,560000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,79900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,92300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,291500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1023700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1023700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-195400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-145400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1170400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,961400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-28300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-578100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-578100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-470900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-328000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,622400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,135500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-41000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-41000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,399800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,280200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,280200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,61000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,27700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,399400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,399400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-71500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-443100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,81600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-12300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-445300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-445300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,6900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,35000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,37000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,37000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1046900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1046900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,89300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,25300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,216200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-198300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1179400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1179400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-254400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-159200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-568100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,409900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-24000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-595800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-595800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-31700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-263300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,18900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,160500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-115600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-115600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,FY,2019-01-01,2019-12-31,2020-02-14 16:13:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,468000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,773700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,773700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,85300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,18700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,300000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-104700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1073000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1073000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-240500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-159200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-279000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,548400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-14500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-144800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-144800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-628300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-535300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,13100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,153200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-997300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-997300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-68200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,274700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,274700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,49600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,83000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,437300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,437300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-76100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,87500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-4500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-12700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-12700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-5600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,2300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,39000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,34400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,34400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,459800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,766700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,766700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,65400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,18700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,155200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-226000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,780000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,780000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-182900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-159200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-125000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,328300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-11700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-150500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-150500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-26800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-263300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,12000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,125500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-152600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-152600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q3YTD,2019-01-01,2019-09-30,2019-10-25 16:08:59+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,472500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,724900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,724900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,81400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,11800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,268800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-108900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,978000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,978000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-249500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-159200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-564700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,601500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-14400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-386300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-386300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-622400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-627100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,11900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,149200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1088400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1088400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-493100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,242300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,242300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,67800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,341200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,341200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-64600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-107400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-72200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,164700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-8800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-88300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-88300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-17200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-256300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,41500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-231400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-231400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,492000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,492000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,42300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,11800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,105600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-309000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,342700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,342700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-106800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-159200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-105400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,240800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-7200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-137800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-137800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-21200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-262000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,86500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-187000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-187000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-5200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q2YTD,2019-01-01,2019-06-30,2019-07-26 16:05:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,249700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,249700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,37800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-312300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-51800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-33200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,76100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-49500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-49500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-5700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,9100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,45000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,44400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,44400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1,2019-01-01,2019-03-31,2020-04-27 19:56:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,765300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,765300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,78900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,5700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,221200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-294100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,777000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,777000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-237700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-50000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-489400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,596600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-12600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-193100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-193100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1122700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-799100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,692000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,147200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-15100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1097700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1097700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,3800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-510000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,1107800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1107800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,93200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,26300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,217000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-59400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,1384900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,1384900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-294400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,-107400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-799200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,562100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-42100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-681000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-681000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-36300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-872400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,17700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,144600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-746400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-746400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-42500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,310600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,310600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,24500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,6700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,38600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-173400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,207000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,207000000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-82200000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-264300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,228300000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-16500000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-134700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-134700000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8600000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-614800000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,7900000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,29100000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-586400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-586400000.0
Edwards Lifesciences Corp,EW,YA13X31F3V31L8TMPR58,0001099800,2020.0,Q1,2020-01-01,2020-03-31,2020-04-27 19:56:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-514100000.0
